|
Market Closed -
Nasdaq
00:00:00 02/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 8.940 USD | -5.60% |
|
+4.32% | -69.02% |
| 09-14 | Capricor Therapeutics Shares Rise After Upgrade From B. Riley | MT |
| 09-14 | B. Riley Upgrades Capricor Therapeutics to Buy From Neutral, Raises Price Target to $21 From $5 | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 520M | - | - | - | - | - |
| 74.41B | |||||
| 59.26B | |||||
| 47.14B | |||||
| 42.91B | |||||
| 44.13B | - | - | - | - | - |
Select your edition
All financial news and data tailored to specific country editions
